*	OR T2 T3
R1	Has_value Arg1:T5 Arg2:T6	
R2	Has_temporal Arg1:T5 Arg2:T7	
R3	multi Arg1:T9 Arg2:T14	
R4	Has_value Arg1:T8 Arg2:T9	
R5	Has_qualifier Arg1:T8 Arg2:T10	
R6	Has_value Arg1:T12 Arg2:T13	
R7	Has_value Arg1:T17 Arg2:T18	
R8	Subsumes Arg1:T20 Arg2:T21	
R9	Has_value Arg1:T19 Arg2:T20	
R10	Has_index Arg1:T24 Arg2:T25	
R11	Has_negation Arg1:T23 Arg2:T22	
R12	Has_temporal Arg1:T23 Arg2:T24	
R13	Has_qualifier Arg1:T28 Arg2:T29	
R14	Has_qualifier Arg1:T30 Arg2:T32	
R15	Has_context Arg1:T26 Arg2:T28	
*	OR T39 T40
R16	AND Arg1:T37 Arg2:T39	
R17	Has_qualifier Arg1:T8 Arg2:T11	
R18	AND Arg1:T26 Arg2:T27	
R19	AND Arg1:T37 Arg2:T38	
T1	Condition 0 7	Healthy
T2	Person 8 12	male
T3	Person 16 22	female
T4	Person 23 34	adolescents
T5	Person 36 39	age
T6	Value 40 54	12 to 17 years
T7	Temporal 67 79	at Screening
T8	Measurement 88 109	body mass index (BMI)
T9	Value 118 197	greater than or equal to the United States-weighted mean of the 95th percentile
T10	Qualifier 198 210	based on age
T11	Qualifier 198 206;215 218	based on sex
T12	Measurement 226 237	body weight
T13	Value 238 268	greater than 60 kilograms (kg)
T14	Value 118 142;178 197	greater than or equal to the 95th percentile
T16	Non-representable 270 369	Participants with Type 2 diabetes mellitus (T2DM) may have a pre-existing or new diagnosis of T2DM.
T17	Measurement 371 376	HbA1c
T18	Value 377 382	=6.5%
T19	Measurement 384 412	fasting plasma glucose (FPG)
T20	Value 413 423	=126 mg/dL
T21	Value 425 435	7.0 mmol/L
T22	Negation 470 473	not
T23	Mood 474 495	planning to move away
T24	Temporal 510 539	for the duration of the study
T25	Reference_point 530 539	the study
T26	Observation 563 580	willing to comply
T27	Observation 554 558;571 580	able to comply
T28	Observation 638 658	reduced calorie diet
T29	Qualifier 624 636	standardized
T30	Observation 683 718	increased physical activity program
T32	Qualifier 666 681	age appropriate
T34	Observation 747 760	stable health
T35	Non-query-able 761 795	in the opinion of the investigator
T36	Non-representable 797 1016	Able and willing to support and supervise study participation in the opinion of the investigator, including consideration of any existing physical, medical, or mental condition that prevents compliance with the protocol
T37	Observation 1027 1055	willing to personally comply
T38	Observation 1018 1022;1035 1055	Able to personally comply
T39	Person 1119 1129	caregivers
T40	Person 1133 1142	guardians
